Group 1 - The core viewpoint of the report is a recommendation rating for Meihua Biological (600873.SH) with a latest price of 11.02 yuan [2] - The reasons for the rating include the increase in the volume and price of lysine, leading to stable overall revenue [2] - The company is committed to its main business while expanding overseas and through acquisitions, marking the beginning of a new journey [2]